The drug normalizes mutated hematopoietic stem cells, which are the cause of diabetes. This approach addresses the fundamental cause of diabetes and its complications. Not only does it reduce the frequency of insulin injections traditionally required, but it also potentially eliminates the need for them entirely. This is expected to significantly improve the daily quality of life for pets.